CRM Platform Development

About Histide

Histide is a private, Paris-based biotech developing an innovative extracellular therapeutic platform centered on Cell Recoding Molecules (CRM). This approach seeks to treat diseases by providing precise extracellular signals to reprogram cell behavior without genetic modification, positioning it as a potential breakthrough for untreatable conditions. The company is pre-clinical and pre-revenue, building its intellectual property portfolio and pipeline with a leadership team combining deep scientific and IP expertise. Key validation includes a published Nature paper on stem cell differentiation mechanisms.

Therapeutic Areas